RecallDepth
Class II Ongoing

Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceutical Inc., Berkeley Heights, NJ 07922 NDC 51991-748-10.

Company
Breckenridge Pharmaceutical, Inc.
Recall Initiated
November 24, 2025
Posted
December 10, 2025
Recall Number
D-0216-2026
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
7389 bottles
Firm Location
Berkeley Heights, NJ, United States

Reason for Recall

CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit

Distribution

Nationwide within the United States

Lot / Code Info

Lot #: 240534C, Exp. Date 01/2027; 240977C, Exp. Date 04/2027.

More recalls by Breckenridge Pharmaceutical, Inc.

View all recalls by this company →

Other recent Class II Drug recalls